Minimum age set for puberty blockers trial To participate in the ‘PATHWAYS’ clinical trial, a modified protocol has ruled that birth-registered females must be aged between 11 and 16 years, and birth-registered males must be aged between 12 and 16 years.…
Pharmacy regulator warns against promotion of prescription weight-loss medicines A notice has reminded businesses that they cannot advertise prescription-only medicines or prescription-only medical treatments to the public.…
Asda Pharmacy launches ‘judgement-free’ disposal scheme as access to unregulated medication rises One-quarter of GPs said they have encountered patients who require hospital care following complications associated with unregulated medicines.…
MHRA issues drug safety warning over ACE inhibitor side effect A drug safety warning has advised clinicians that ACE inhibitors should be halted immediately if a patient is suspected of presenting with angioedema during treatment.…
Regulator investigating pharmacists following report on gender prescribing at GP practice Exclusive: The General Pharmaceutical Council said it opened its investigation after a report revealed how “potential harm” had been caused to 78 children and young people seeking support for gender dysphoria or incongruence.…
GPhC chair among pharmacists celebrated in King’s Birthday Honours Gisela Abbam, chair of the General Pharmaceutical Council, has been recognised for her services to pharmacy.…
MHRA approves semaglutide oral tablets for weight loss The Medicines and Healthcare products Regulatory Agency advises that patients must start at the lowest 1.5mg daily dose of oral semaglutide tablets, which can be further increased to 4mg, 9mg and 25mg doses.…
The Critical Medicines Act: can the UK manage supply problems with the EU’s ‘safety belt’? Pharmacy leaders are hopeful that the Critical Medicines Act will help to alleviate medicines shortages in the UK, which have been rumbling on for several years.…
Kathie Cashell: ‘You can’t protect the public without an empowered profession’ As fitness-to-practise complaints to the General Pharmaceutical Council hit record highs, we spoke to new chief executive Kathie Cashell about her priorities for the organisation and the improvements she wants to deliver.…
Regulator vows to prioritise racism review recommendations General Pharmaceutical Council chief executive, Kathie Cashell, said “urgent, demonstrable and visible action is needed by all leaders”, following the publication of the Mann review.…
